BioSpace News Archive

Findings show that alvocidib potentiates the activity of apoptosis-inducing agents cytarabine and daunorubicin (7+3) in non-clinical models

Incyte Corporation announced that it has scheduled its first quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, May 1, 2018.

- Early access researchers will present data at the annual meeting of the American Association for Cancer Research in Chicago this week. -

Omeros Corporation (NASDAQ: OMER) today announced that the results of four studies directed to the benefits of OMIDRIA across a range of clinical situations in cataract surgery will be presented at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Congress in Washington, D.C., April 13-17, 2018.

The Genoox Integrated Platform is Designed to Offer Solutions for Combining Genoox Technology for Aligning and Calling NGS Short-Reads with Bionano Genome Mapping Technology to Better Understand Complexities of DNA Mutations

Endo International plc will announce its first-quarter 2018 financial results on May 8, 2018 and members of its senior management team will host a conference call and webcast before the U.S. financial markets open at 7:30 a.m. ET.

Allergan plc announced the official launch of TrueTear®, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients.

Strategic Additions Bring Global Operations and Commercialization Expertise

Treatment with TyrNovo’s NT219 in combination with targeted cancer drugs, as well as chemotherapy and immuno-oncology therapies, prevented acquired resistance and reversed resistance of colon, lung and head-and-neck cancers in patient-derived xenograft models

Company to Focus Resources on GVHD and Pain Programs